| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.468 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| BMX |
IPI00514142 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| CCL11 |
CCL11, SCYA11: Eotaxin precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL11 |
CCL11, SCYA11: Eotaxin precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.468 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.468 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.468 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.468 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.468 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| OXTR |
OXTR: Oxytocin receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| OXTR |
OXTR: Oxytocin receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.468 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.468 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.468 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.468 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.468 |
Evidence |
|